Prednizon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prednizon

Quick Facts

Property Description
Active ingredient Prednisolone Acetate
Pharmacological class Glucocorticoid / Corticosteroid
Primary Forms Oral Tablet, Oral Solution, Ophthalmic Suspension
Origin Synthetic
General Purpose Managing severe inflammation and immune system activity

Prednizon's Identity: A Synthetic Glucocorticoid

Prednizon is a potent, synthetic medication containing the active ingredient Prednisolone Acetate, which is formally classified as a powerful glucocorticoid. This substance belongs to the family of adrenocortical steroids and is chemically engineered to mimic the actions of cortisol, the natural hormone produced by the body's adrenal glands. The parent compound, prednisolone, has a long history of use in clinical medicine. As a prescription-only (Rx) drug, its primary molecular action is to function as a glucocorticoid receptor (GCR) agonist, engaging cellular mechanisms that suppress inflammation and immune responses throughout the body.

Active Composition and Available Forms

The core composition is the active ingredient Prednisolone Acetate, which is chemically an ester of the compound Prednisolone. This specific acetate ester is often utilized in preparations designed for local (topical) administration, such as ophthalmic suspensions, a feature distinguishing it from non-esterified prednisolone. Prednizon is manufactured as a single-ingredient product and is available in multiple dosage forms, including oral tablets and oral solutions for systemic absorption, as well as ophthalmic suspensions for direct application to the eye.

General Purpose: Managing Inflammation and Immune Activity

The general purpose of a potent glucocorticoid like Prednizon is to provide control over significant inflammation and heightened immune activity, such as in scenarios involving severe allergic or autoimmune responses. The compound functions as an anti-inflammatory agent and an immunosuppressant agent. By acting on the underlying cellular processes associated with swelling, redness, and pain, the drug is used to help stabilize the body during acute phases of inflammation or chronic conditions driven by an overactive immune system. Prednisolone is a widely utilized therapeutic agent for controlling serious inflammatory conditions.

Regulatory References

  1. DailyMed
  2. MedlinePlus
  3. WHO Essential Medicines

What side effects are possible with Prednizon?

Possible side effects and safety information

Regulatory documents classify the adverse effects of Prednizon (prednisolone acetate) by the body system affected and their expected frequency. The safety profile is structured to distinguish between common, less common, and serious reactions observed in clinical use.

Adverse Reaction Scope

Component Description (Based on Regulatory Labels)
Key Adverse Reaction Categories Adrenal suppression, Cushingoid features, Fluid/electrolyte disturbances, Increased susceptibility to infection, Gastrointestinal ulceration, Musculoskeletal damage (e.g., Osteoporosis, Myopathy).
Frequency Classification Adverse effects are classified using standard frequency categories: Very Common, Common (e.g., weight gain, fluid retention, mood changes, increased appetite), Uncommon, Rare (e.g., acute pancreatitis, aseptic necrosis), and Very Rare in systemic use documents.
System-Organ Classes Involved Endocrine disorders, Metabolism and nutrition disorders, Musculoskeletal and connective tissue disorders, Gastrointestinal disorders, Nervous system disorders, Psychiatric disorders, Eye disorders, and Infections and infestations are principal categories listed in regulatory texts.
Serious Adverse Reactions Acute secondary adrenocortical insufficiency (particularly upon abrupt cessation), Gastrointestinal perforation and hemorrhage, Aseptic necrosis of bone, Severe and opportunistic infections, Glaucoma, and Acute pancreatitis are documented as serious adverse events.

Safety Considerations and Patterns

The official safety information notes specific patterns related to exposure and duration. Adrenal suppression and Cushingoid features are generally associated with prolonged systemic exposure and higher doses. A withdrawal syndrome is a documented pattern associated with abrupt cessation following long-term therapy.

Population-Specific Safety: The pediatric population is explicitly noted in labeling for the potential risk of growth retardation with extended systemic use. Systemic use is contraindicated in patients with active systemic fungal infections, a key restriction included in regulatory documents.

These official safety data points structure the risk profile by classifying adverse reactions based on their frequency and the physiological systems affected, defining the medicine's safety boundaries without offering interpretation or advice.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents classify the potential risk associated with Prednizon (prednisolone) overdose based on the type of exposure. Acute overdosage from a single ingestion is generally documented as unlikely to cause life-threatening toxicity. However, immediate medical attention and contact with a Poison Control Center or Emergency Room is mandatory for any suspected overdose.

Manifestations of overdose are primarily linked to chronic overdosage or prolonged high-dose use, which may lead to specific physiological disturbances.

Officially Documented Overdose Manifestations and Actions

Exposure Context Documented Manifestations
Acute Event Unlikely to cause acute severe problems.
Chronic Overuse Fluid retention, electrolyte disturbance (e.g., hypokalemia), hypertension, and features of a Cushingoid state.

Management is symptomatic and supportive, as no specific antidote is known for prednisolone. The regulatory mandate includes providing necessary treatment to correct documented findings, such as severe electrolyte imbalance. Hospital monitoring may be required, with a specific focus on evaluating serum electrolyte levels and blood pressure. For pediatric patients on prolonged high-dose therapy, official guidance requires close monitoring of growth and development due to the risk of HPA-axis suppression.

Therapeutic Uses of Prednizon

What Prednizon Treats: Main Uses and Benefits

Prednizon (prednisolone) is a medication commonly applied across conditions that are characterized by symptoms related to inflammatory or irritative states. The medication is used to address symptom clusters that may become intense or disruptive in conditions presenting with acute episodes. It is relevant in therapeutic domains involving conditions marked by increased physiological stress, including autoimmune disorders like rheumatoid arthritis and Lupus, symptoms related to heightened physiological activity such as allergic reactions, and various respiratory illnesses including asthma exacerbations.

When symptoms interfere with daily comfort, Prednizon provides supportive relief during these difficult episodes. It is utilized when symptoms intensify, assisting with managing symptoms related to physical discomfort. This helps patients cope more steadily with symptom fluctuations. It may also be considered relevant in settings requiring replacement therapy for adrenocortical insufficiency or providing supportive benefit to organ transplant recipients.


Quick Fact: Relief for Systemic and Localized Discomfort Symptom Type Context of Use Primary Benefit
Swelling and Pain Autoimmune flares, Joint discomfort Eases the overall symptom burden
Breathing Distress Acute allergic episodes, Respiratory illnesses Assists with maintaining functional stability
Redness and Sensitivity Ocular inflammation, Post-surgical care Supports general well-being during symptomatic phases

Regulatory References

  1. DailyMed label from the NIH and FDA

Eligibility and Restrictions for Use

Prednizon is generally used in both adult and pediatric populations, but its use is subject to strict regulatory conditions and contraindications based on government and official medical labeling.

Contraindicated Populations

Use is prohibited for patients with:

  • Systemic fungal infections.
  • Known hypersensitivity or allergy to prednisone or any component of the drug product.
  • Herpes simplex eye infection or cerebral malaria.

Restricted/Special Consideration Use

Physicians must exercise caution and close monitoring is required for patients with various conditions, including:

  • Existing infections (viral, bacterial, fungal) or exposure to infections like chickenpox or measles, due to the drug's immunosuppressive effects.
  • Latent tuberculosis or tuberculin reactivity, as this may cause reactivation.
  • Recent myocardial infarction (heart attack).
  • Ocular herpes simplex, osteoporosis, diabetes mellitus, hypertension, and liver cirrhosis.

Age and Physiological Restrictions

  • Pediatric patients on long-term therapy require close monitoring for effects on growth and development.
  • Geriatric patients may require dose adjustment due to age-related organ function changes.
  • Live or live attenuated vaccines are prohibited for individuals receiving immunosuppressive doses of the medication.
  • Use during the first trimester of pregnancy has been associated with potential fetal harm.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prednizon (Prednisone) is subject to clinically significant interactions with several classes of medicinal products, primarily classified based on their effect on the steroid's concentration or their additive pharmacological action.

Pharmacokinetic Interactions

Prednizon's concentration in the body is significantly affected by drugs that modify the CYP 3A4 enzyme system in the liver. Inducers (e.g., Rifampin, Phenytoin) accelerate the steroid's clearance, which may reduce its effectiveness. Conversely, Inhibitors (e.g., Ketoconazole, Macrolides, Estrogens) can decrease the steroid's clearance, potentially raising its concentration and the risk of adverse effects. Additionally, Cyclosporine co-administration may increase the activity of both agents.

Pharmacodynamic and Restricted Interactions

Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or salicylates carries an increased risk of gastrointestinal ulceration or bleeding. Similarly, concurrent use with Potassium-Lowering Agents (e.g., diuretics, Amphotericin B) enhances the risk of hypokalemia. Antidiabetic agents may require dosage adjustment due to the steroid's effect on blood glucose. A critical restriction is the absolute contraindication of Live or Live Attenuated Vaccines during immunosuppressive corticosteroid therapy, due to the risk of serious complications and lack of immune response.

Mechanism of Action

How Prednizon Works: Mechanism of Action

Prednizon is a prodrug that is converted in the liver to its active form, prednisolone. Prednisolone acts as an agonist for the ubiquitous Glucocorticoid Receptor (GR), a nuclear transcription factor. Upon cellular entry, prednisolone binds to the GR, and the resulting complex translocates into the nucleus.

This molecular interaction results in two primary mechanistic cascades. First, through transrepression, the complex inhibits pro-inflammatory transcription factors, such as NF-κB, thereby blocking the genetic production of inflammatory mediators like cytokines and chemokines. Second, through transactivation, it upregulates the synthesis of anti-inflammatory proteins, such as annexin A1. This dual action leads to the suppression of the immune and inflammatory response.

Physiologically, this mechanism also impacts metabolic and endocrine systems. Prednisone promotes hepatic gluconeogenesis and increases protein catabolism. Furthermore, its presence activates the negative feedback loop of the HPA axis, resulting in the inhibition of the body's natural cortisol production.

Dosage and Administration Information

How Prednizon is used: Administration Guidelines

Prednizon, which contains prednisolone or prednisolone acetate, is administered via the oral route for systemic therapy (tablets and solutions) and the topical ophthalmic route (suspensions) for local treatment. The dosing schedule is highly individualized and determined by clinical need.

Administration Method Labeled Dosing and Frequency
Oral (Systemic) Initial Adult Dose: Typically ranges from 5 mg to 60 mg daily.
Maintenance Dose: The lowest dosage that sustains a clinical response.
Frequency: Often taken as a single dose in the morning, or in divided doses.
Ophthalmic (Local) Dose: 1 to 2 drops instilled into the affected eye(s).
Frequency: Usually 2 to 4 times daily; frequency may be increased during the initial 24 to 48 hours.

Procedural Instructions and Use Patterns

Instructions typically include specific guidance on how the medicine is taken:

  • Intake Conditions: Oral forms are taken with food or milk to reduce the risk of gastrointestinal irritation.
  • Preparation: Ophthalmic suspensions are shaken well before each use. Oral solutions are accurately measured using a calibrated device.
  • Duration and Tapering: Following prolonged systemic use, the drug is withdrawn gradually (tapered) rather than stopped abruptly to prevent withdrawal effects.
  • Population and Stress: Dosage may require adjustment (increase) during periods of unusual physiological stress, such as major illness or surgery.
  • Special Tablets: Specific delayed-release oral tablets are swallowed whole and not crushed, broken, or chewed.

Recent Clinical Evidence

Research evidence / Overview of studies for Prednizon

Evidence for Use in Systemic Inflammatory and Autoimmune Conditions

This section will summarize the types of controlled clinical trials, observational studies, and systematic reviews that established the research framework for studies evaluating generalized inflammation, severe allergic states, and chronic autoimmune disorders.

Prednizon, through its active form, was evaluated in a wide range of studies for conditions characterized by fluctuating or episodic manifestations across the body, such as autoimmune flares, severe allergies, and certain respiratory illnesses. The research examined outcomes linked to inflammatory or irritative states, focusing on measurements of physical discomfort, swelling, and changes in the frequency of acute episodes. While this medication is often referenced in research and guidelines related to the standard approach to care for acute, severe inflammation, certain research limitations exist.

Evidence for Use in Localized Ocular Inflammation

This part will focus on the research base for the eye drop formulation, detailing the Randomized Controlled Trials (RCTs) and meta-analyses that examined inflammatory outcomes following eye surgery and for steroid-responsive inflammation inside the eye.

Research on the eye drop formulation was studied for conditions associated with acute or disruptive episodes, specifically inflammation that occurs following eye surgeries or for certain inflammatory conditions of the eye itself. These evaluations largely consist of modern, high-quality Randomized Controlled Trials (RCTs). The studies monitored outcomes linked to inflammatory states within the eye, primarily focusing on the presence and intensity of specific biological markers like anterior chamber (AC) cells and AC flare.

Research Gaps and Areas of Uncertainty

This final summary will clarify the key limitations noted in the research landscape, such as where evidence relies heavily on older data or where long-term outcomes are less characterized by large-scale controlled studies.

One primary research limitation is that the comparative evidence is lacking for many new treatments because Prednizon is historically referenced in research as a comparator or baseline therapy. There is a noted absence of recent, large-scale, placebo-controlled Randomized Controlled Trials (RCTs) for certain long-standing systemic uses. For localized use, there is limited information for long-term outcomes regarding the duration of reduced inflammation once the treatment is discontinued. Additionally, subgroup findings are uncertain for specific populations where data are still emerging.

Key Studies & References

  1. Prednisolone Acetate Ophthalmic Suspension (FDA Label/DailyMed)
  2. Prednisolone: MedlinePlus Drug Information (Systemic and General Uses Synthesis)
  3. Prednisone - eEML - Electronic Essential Medicines List (WHO)

Frequently Asked Questions (FAQ)

Common questions about Prednizon (FAQ)

Q: What is the difference between Prednizon and prednisolone?

Prednizon (prednisone) is described in official documents as a prodrug. This means the medication itself is not fully active when swallowed. Once it enters the body, it is converted by the liver into its active medicinal form, which is prednisolone.

Q: Can Prednizon be taken at the same time as pain relievers like ibuprofen?

Regulatory documents indicate that combining this medication with non-steroidal anti-inflammatory agents (NSAIDs), such as ibuprofen, increases the potential risk of certain gastrointestinal side effects. These risks include the possibility of stomach ulceration or bleeding. Patients should discuss all current medications with their prescribing health professional.

Q: Does Prednizon have any listed contraindications related to mental health conditions?

Official labels do not list pre-existing mental health conditions as an absolute contraindication, a reason the drug must not be used. However, they do caution that psychiatric disturbances, such as mood swings, confusion, and psychosis, are possible side effects. Regulatory documents note that caution is required for patients with existing emotional instability, as the drug's effects may aggravate these tendencies.

Q: Are there any foods or drinks that should be avoided when on Prednizon?

Official administration instructions advise taking oral forms of Prednizon with food or milk to help reduce the possibility of stomach irritation. While official regulatory information does not typically list specific foods or drinks that must be strictly avoided, concerns regarding fluid retention that can occur with this medicine may suggest a general awareness of sodium intake.

Q: Is Prednizon used for conditions other than inflammation?

Yes, official regulatory labels indicate that Prednizon is approved for use in a variety of conditions beyond its powerful anti-inflammatory actions. These uses include treating certain endocrine disorders (like adrenocortical insufficiency), hematologic disorders (blood problems), and neoplastic diseases (certain cancers).

Q: Do you get side effects right away after starting Prednizon?

Official safety documents classify side effects by how often they occur, but they do not list the exact time of onset. Evidence suggests that some common effects, such as mood changes and increased appetite, may be noticed relatively early in the treatment course. In contrast, serious side effects, such as bone or vision changes, are typically associated with prolonged systemic use.

Q: Can Prednizon affect your sleep schedule?

Yes, official safety information lists insomnia (difficulty falling or staying asleep) as a possible adverse reaction. This is noted under the classification of psychiatric adverse effects that may be associated with the use of this medication.

Q: Is it common to gain weight while using Prednizon?

According to official regulatory documents, weight gain and increased appetite are classified as Common adverse reactions. This classification means these effects are among the most frequently reported during the use of this medication.

Q: Is it possible to take Prednizon for a very long time?

This medication can be prescribed for both short- and long-term use, depending on the condition being treated. For long-term therapy, official documents caution that the likelihood of complications is dependent on both the dosage amount and the duration of treatment. Due to the way the drug affects the body’s natural hormones, gradual reduction (tapering) is necessary to avoid adrenal insufficiency after prolonged use.

Q: Can older people use Prednizon safely?

Official documents state that specific geriatric problems that would inherently limit the drug's usefulness have not been demonstrated. However, caution is advised because older adults are more likely to have age-related issues, such as bone density loss or organ function changes. These factors may necessitate careful monitoring and, potentially, a dose adjustment.

Q: What safety class does Prednizon belong to?

Prednizon belongs to the pharmacological class of medicines called corticosteroids, which is a general term for drugs that act like steroid hormones. More specifically, it is categorized as a glucocorticoid, which is recognized for its powerful anti-inflammatory and immunosuppressive actions.

Q: Can Prednizon cause changes to vision or eyes?

Official safety information lists a number of possible adverse reactions affecting the eyes. These include the potential development of glaucoma (increased pressure in the eye), posterior subcapsular cataracts, and exophthalmos (a condition causing the protrusion of the eyeball).

Q: What happens if you miss a dose of Prednizon?

Regulatory instructions describe that a missed dose is taken as soon as it is remembered, unless the time is near the next scheduled dose. Specific guidance on missed doses can be found in the drug’s full labeling.

Q: How does Prednizon interact with diabetes medications?

Official documents state that Prednizon has the potential to increase blood glucose (sugar) concentrations. This effect can potentially reduce the effectiveness of antidiabetic agents, such as insulin or oral medications used for diabetes management. Because of this interaction, a dosage adjustment for the diabetes medication may be required.

Q: Are there any known interactions between Prednizon and common vaccines?

Official warnings state that patients using corticosteroid therapy may exhibit a diminished response to certain vaccines that are non-live. Furthermore, the use of live or live-attenuated vaccines is strictly restricted due to the potential for the weakened organisms in the vaccine to cause serious complications, particularly at immunosuppressive doses.

Q: How quickly do the effects of Prednizon wear off after stopping?

The drug itself is eliminated from the bloodstream within about 15 to 20 hours after the last dose, according to pharmacokinetic data. However, the drug’s biological effects on the body, such as the suppression of the body’s natural cortisol production, can persist for a longer period. This is the reason why official guidance requires the drug to be gradually discontinued (tapered) after prolonged use.

Q: What does official guidance say about using Prednizon during pregnancy or breastfeeding?

Regarding pregnancy, official documents state that infants born to mothers who received substantial doses should be closely monitored for signs of hypoadrenalism (low function of the adrenal gland). When breastfeeding, official documents caution that the drug is present in human milk. Official documents note that the presence of the drug in human milk means that the patient’s health professional must weigh the importance of the medication against the considerations of breastfeeding.

Q: What is the general advice for sun exposure while using Prednizon?

Official labeling does not list sun sensitivity (photosensitivity) as a specific side effect. However, the drug is documented to cause dermatological changes like thin or fragile skin, as well as bruising. This suggests a general need for patients to be mindful and protective of their skin health while using this medication.

Q: Can Prednizon interact with herbal products or traditional medicines?

Official guidance warns that there is limited information regarding taking herbal products or traditional medicines concurrently with this prescription drug. It advises patients to inform their health professional about all remedies being used, as these products are not tested in the same way as prescription medicines and may carry unknown risks.

Q: How is the safety of Prednizon monitored after it is approved?

The safety of approved medicines is continually monitored by regulatory bodies through programs such as Post-Marketing Surveillance (PMS). These systems actively collect reports of adverse events from health professionals and the public. Based on this ongoing monitoring, official drug labels are periodically updated with the latest safety information.

Q: What official information is available on children using Prednizon?

Official documents explicitly warn that the long-term use of this drug in pediatric patients may result in the suppression of growth and development. For this reason, official guidance states that children on long-term therapy must have their growth and development closely and regularly monitored.

Q: Is Prednizon considered a first-line treatment for its primary uses?

The active compound is included on the World Health Organization's Model List of Essential Medicines, confirming its global recognition as a core medicine for serious inflammation. Research evidence often references it as a standard approach or baseline therapy in many clinical trials for acute, severe inflammatory conditions.

How should Prednizon be stored and disposed of?

Storage Requirements

Prednisolone oral tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted temperature excursions. The tablets must be protected from moisture and stored in a tight container. For the ophthalmic suspension, the required storage temperature is 8 C to 24 C (46 F to 75 F), and the product must be protected from freezing. All formulations must be kept out of the reach of children to prevent accidental ingestion.

Disposal Instructions

Official regulatory guidelines require that any unused or expired product be disposed of according to local regulations for pharmaceutical waste. The U.S. Food and Drug Administration (FDA) recommends using a drug take-back program or following their specific instructions for safe household disposal if a take-back program is not available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednizon found in:

A-Z Index: